Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 2 March 2010
Vol. 3, Issue 111, p. ec70
[DOI: 10.1126/scisignal.3111ec70]

EDITORS' CHOICE

Inflammation Limiting Inflammatory Signaling

L. Bryan Ray

Science, Science Signaling, AAAS, Washington, DC 20005, USA

Dysregulation of the transcription factor NF-{kappa}B causes chronic inflammation, autoimmunity, and malignancy. The zinc finger protein A20 is vital for regulating NF-{kappa}B signaling, so much so that mice lacking A20 die young of multiorgan failure and cachexia. Similar deficiencies have been seen in Crohn’s disease, rheumatoid arthritis, and other inflammatory diseases of humans. But how A20 works has remained unknown. Shembade et al. (see the Perspective by Sriskantharajah and Ley) have discovered that the A20 protein acts through the ubiquitin labeling system of the cell required for normal protein turnover and its lack prevents NF-{kappa}B recycling, resulting in chronic inflammation. A human T cell lymphotropic virus possesses an oncoprotein that subverts this pathway to the virus’s benefit by inhibiting A20 interactions with the ubiquitin pathway to promote NF-{kappa}B signaling and cell immortalization.

N. Shembade, A. Ma, E. W. Harhaj, Inhibition of NF-{kappa}B signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135–1139 (2010). [Abstract] [Full Text]

S. Sriskantharajah, S. C. Ley, Turning off inflammation signaling. Science 327, 1093–1094 (2010). [Summary] [Full Text]

Citation: L. B. Ray, Limiting Inflammatory Signaling. Sci. Signal. 3, ec70 (2010).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882